Published in J Clin Microbiol on August 01, 2001
Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol (2009) 3.18
Rapid detection of Clostridium difficile in feces by real-time PCR. J Clin Microbiol (2003) 3.08
Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol (2006) 2.72
Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol (2007) 2.05
Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol (2009) 1.97
Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile? J Clin Microbiol (2008) 1.88
Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J Clin Microbiol (2003) 1.87
C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J Clin Microbiol (2009) 1.55
Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. J Clin Microbiol (2007) 1.49
Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces. J Clin Microbiol (2009) 1.30
High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection. Eur J Clin Microbiol Infect Dis (2003) 1.20
Rapid and simple method for detecting the toxin B gene of Clostridium difficile in stool specimens by loop-mediated isothermal amplification. J Clin Microbiol (2005) 1.07
Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection. Clin Vaccine Immunol (2008) 1.03
Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol (2010) 0.97
Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens. Eur J Clin Microbiol Infect Dis (2007) 0.94
Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool. J Clin Microbiol (2014) 0.89
Repeated enzyme immunoassays have limited utility in diagnosing Clostridium difficile. Eur J Clin Microbiol Infect Dis (2008) 0.79
Single domain antibody coated gold nanoparticles as enhancer for Clostridium difficile toxin detection by electrochemical impedance immunosensors. Bioelectrochemistry (2015) 0.76
Frequency of Clostridium difficile among patients with gastrointestinal complaints. Gastroenterol Hepatol Bed Bench (2011) 0.75
Evaluation of commercially available rapid assays: a manufacturer's perspective. J Clin Microbiol (2001) 0.75
Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol (1995) 4.39
Clostridium difficile--associated diarrhea. Clin Infect Dis (1998) 4.06
Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (1997) 3.70
Clostridium difficile infection. Annu Rev Med (1998) 3.63
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol (2000) 2.50
Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J Clin Microbiol (1992) 2.18
Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J Clin Microbiol (1998) 2.09
An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep (1999) 2.04
Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile. J Clin Microbiol (2000) 1.91
Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. J Clin Microbiol (1998) 1.89
Clinical impact and associated costs of Clostridium difficile-associated disease. J Antimicrob Chemother (1998) 1.78
Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol (1993) 1.77
Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol (1996) 1.49
Comparison of the TOX A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools. Diagn Microbiol Infect Dis (2000) 1.49
Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens. Clin Microbiol Infect (2001) 1.30
Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens. J Clin Microbiol (1999) 1.23
The lack of value of repeated Clostridium difficile cytotoxicity assays. Arch Pathol Lab Med (1996) 1.22
Laboratory assessment of five enzyme immunoassay Clostridium difficile toxin detection kits. Br J Biomed Sci (1999) 0.86
Equity and the NHS: self-reported morbidity, access, and primary care. Br Med J (1980) 3.72
Controlled trial of mobilisation and manipulation for patients with low back pain in general practice. Br Med J (1978) 3.53
GenBank. Nucleic Acids Res (1991) 2.67
Controlled trial of mobilisation and manipulation for low back pain: hospital patients. Br Med J (1979) 1.95
X-linked mental retardation without physical abnormality: Renpenning's syndrome. Dev Med Child Neurol (1971) 1.95
Antimicrobial resistance and genetic diversity of Shigella sonnei isolates from western Ireland, an area of low incidence of infection. J Clin Microbiol (2003) 1.61
Maternal effects of regular salicylate ingestion in pregnancy. Lancet (1975) 1.52
Changing nurses' pain assessment practice: a collaborative research utilization approach. J Adv Nurs (1995) 1.52
Factors in pin tract infections. Orthopedics (1991) 1.52
Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro Surveill (2003) 1.50
The effect of a change from conventional cardiac enzymes to troponin I on overall hospital costs in patients with suspected myocardial infarction. Ir Med J (2002) 1.45
A pilot scheme for improving the accuracy of serum cholesterol measurement in Scotland and Northern Ireland. Ann Clin Biochem (1993) 1.44
Securing the prehospital airway: a comparison of laryngeal mask insertion and endotracheal intubation by UK paramedics. Emerg Med J (2005) 1.41
Care of central venous catheters for total parenteral nutrition. Nutr Clin Pract (1996) 1.38
Molecular characterization of Irish Salmonella enterica serotype typhimurium: detection of class I integrons and assessment of genetic relationships by DNA amplification fingerprinting. Appl Environ Microbiol (2000) 1.31
Childhood immunization 1979. Disturbing statistics for metropolitan Sydney. Med J Aust (1980) 1.31
Plan and operation of the HANES I augmentation survey of adults 25-74 years United States, 1974-1975. Vital Health Stat 1 (1978) 1.29
Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction. J Hosp Infect (2011) 1.25
High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients. Arch Phys Med Rehabil (1986) 1.24
Lyme disease and glomerulonephritis. Ir Med J (1999) 1.23
Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method. Emerg Infect Dis (1999) 1.21
Fetal effects of regular salicylate ingestion in pregnancy. Lancet (1975) 1.20
Microcystic dystrophy of the cornea. A partial explanation for its pathogenesis. Arch Ophthalmol (1974) 1.20
The ribosomal intergenic spacer region: a target for the PCR based diagnosis of tuberculosis. Tuber Lung Dis (1994) 1.18
Management of depression in the elderly by general practitioners: I. Use of antidepressants. Fam Pract (1995) 1.17
Recurrence risk of mental retardation in sibs. Med J Aust (1971) 1.17
Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat (1997) 1.14
Replication and structure of simian virus 40 chromosomes. Cold Spring Harb Symp Quant Biol (1979) 1.09
Occurrence of Campylobacter in retail foods in Ireland. Int J Food Microbiol (2004) 1.08
Evaluation of a cognitive-behavioural intervention for pregnant injecting drug users at risk of HIV infection. Addiction (1996) 1.07
C-erbB-2 immunostaining: problems with interpretation. J Clin Pathol (1994) 1.06
Semiextended position of intramedullary nailing of the proximal tibia. Clin Orthop Relat Res (1996) 1.05
The Noonan syndrome--a review of the clinical and genetic features of 27 cases. J Pediatr (1973) 1.05
Characterization of bacteriophages used in the Salmonella enterica serovar Enteritidis phage-typing scheme. J Med Microbiol (2009) 1.01
The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system. J Neurochem (1994) 1.00
Cryptosporidium among children with acute diarrhoea in the west of Ireland. J Infect (1987) 1.00
Abdominal Carcinomatosis associated with Vasomotor Disturbances. Proc R Soc Med (1934) 0.99
Comparison of BACTEC MGIT 960 and BACTEC 460 for culture of Mycobacteria. Diagn Microbiol Infect Dis (2000) 0.99
Case management: A critical review of the outcome literature. Eur Psychiatry (1995) 0.97
Evaluation of the BACTEC MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis. J Clin Microbiol (2000) 0.96
Salmonella enterica serovar Agona European outbreak associated with a food company. Epidemiol Infect (2010) 0.96
Antimicrobial resistance in E.coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci (2006) 0.95
Evaluation of a PCR/DNA probe colorimetric membrane assay for identification of Campylobacter spp. in human stool specimens. J Clin Microbiol (2001) 0.93
ARDS following equine ATG therapy. Chest (1987) 0.93
Cost-effective methods for isolation of Salmonella enterica in the clinical laboratory. J Clin Microbiol (1999) 0.93
Exploring historical Canadian foodborne outbreak data sets for human illness attribution. J Food Prot (2009) 0.92
Does gastric acid secretion affect phosphate binding by aluminium phosphate binding gels in chronic renal failure? Nephrol Dial Transplant (1988) 0.92
Mobilization and manipulation for low-back pain. Spine (Phila Pa 1976) (1981) 0.91
Chylopericardium after orthotopic heart transplantation. J Heart Lung Transplant (1992) 0.91
Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents. Am J Med (1982) 0.90
Protein-losing enteropathy in systemic lupus erythematosus. Hum Pathol (1982) 0.90
"It's a hidden issue": exploring the experiences of women with HIV-associated neurocognitive challenges using a disability framework. Disabil Rehabil (2012) 0.89
Antimicrobial resistance and phage types of human and non-human Salmonella enterica isolates in Ireland, 1998-2003. Commun Dis Public Health (2004) 0.89
Neonatal death dwarfism. Australas Radiol (1977) 0.89
Lead extraction in young patients with and without congenital heart disease using the subclavian approach. Pacing Clin Electrophysiol (1996) 0.88
Clonal expansion may account for high levels of quinolone resistance in Salmonella enterica serovar enteritidis. Appl Environ Microbiol (2005) 0.88
Novel quinuclidine-based ligands for the muscarinic cholinergic receptor. J Med Chem (1990) 0.88
Prevalence of dental mottling in school-aged lifetime residents of 16 Texas communities. Am J Public Health (1985) 0.88
A multi-country outbreak of Salmonella Newport gastroenteritis in Europe associated with watermelon from Brazil, confirmed by whole genome sequencing: October 2011 to January 2012. Euro Surveill (2014) 0.88
A large outbreak of cryptosporidiosis in western Ireland linked to public water supply: a preliminary report. Euro Surveill (2007) 0.87
Immigrant nurses' experience of racism. J Nurs Scholarsh (2001) 0.87
Antibiotic resistance amongst Salmonella enterica species isolated in the Republic of Ireland. J Antimicrob Chemother (1998) 0.87
Commonly used disinfectants fail to eradicate Salmonella enterica biofilms from food contact surface materials. Appl Environ Microbiol (2013) 0.87
Peritoneal closure or non-closure at cesarean. Obstet Gynecol (1991) 0.86
Investigation and management of an outbreak of Salmonella Typhimurium DT8 associated with duck eggs, Ireland 2009 to 2011. Euro Surveill (2013) 0.85
Decubitus ulcers and amyotrophic lateral sclerosis. Lancet (1978) 0.85
Flow microfluorometric analysis of P388 murine leukemia after administration of vincristine and maytansine in vivo. J Natl Cancer Inst (1978) 0.85
Developmental regulation of protein phosphatase types 1 and 2A in post-hatch chicken brain. Neurochem Res (1998) 0.84
Failure of single dose amoxycillin as prophylaxis against endocarditis. Br Med J (Clin Res Ed) (1984) 0.84
Detection and diagnosis of mycobacterial pathogens using PCR. Expert Rev Mol Diagn (2001) 0.84
Prevalence, numbers and characteristics of Salmonella spp. on Irish retail pork. Int J Food Microbiol (2009) 0.84
Measuring knife stab penetration into skin simulant using a novel biaxial tension device. Forensic Sci Int (2008) 0.84
Quantitative risk assessment of Cryptosporidium in tap water in Ireland. Sci Total Environ (2009) 0.84
High-dose chemotherapy (CTM) for breast cancer. Bone Marrow Transplant (2000) 0.83
Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity. Bioorg Med Chem Lett (2000) 0.83
Mechanical distention modulates alveolar epithelial cell phenotypic expression by transcriptional regulation. Am J Respir Cell Mol Biol (1999) 0.83
The clinical spectrum of Lyme neuroborreliosis. Ir Med J (2010) 0.83
A prospective, randomized study comparing the effect of augmented biofeedback with sensory biofeedback alone on fecal incontinence after obstetric trauma. Dis Colon Rectum (1999) 0.83
Does a teaching programme improve general practitioners' management of depression in the elderly? J Affect Disord (1997) 0.83
Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999-2001. Int J Antimicrob Agents (2003) 0.83
Outbreak of extended spectrum beta-lactamase producing E. coli in a nursing home in Ireland, May 2006. Euro Surveill (2006) 0.83
The sensitive detection of fluorescently labelled PCR products using an automated detection system. Mol Cell Probes (1995) 0.82
A multi-country outbreak of Salmonella Agona, February - August 2008. Euro Surveill (2008) 0.82
Flow microfluorometric system for screening gynecologic cytology specimens using propidium iodide-fluorescein isothiocyanate. J Histochem Cytochem (1976) 0.82
Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anemia. J Clin Microbiol (2002) 0.82
A comparison of antimicrobial sensitivities of urinary pathogens for the years 1980 and 1990. Ir J Med Sci (1993) 0.81
Multicentric reticulohistiocytosis associated with recurrence of malignant melanoma. J Am Acad Dermatol (1995) 0.81
Hepatitis C in injecting drug-using women during and after pregnancy. J Gastroenterol Hepatol (2000) 0.81